Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Odeum Pharma AB
AB
Active
Org 5566023387
Kungsvillan 1, 546 30
Karlsborg
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2001 · 25 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Manufacture of pharmaceutical preparations
/
Odeum Pharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
0M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
EBITDA
SEK millions
0M
0M
0M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
231
215
235
239
174
Staff expenses
—
—
—
—
—
EBITDA
−283
−392
−165
48
−10
Depreciation & amort.
−76
−76
−76
−76
−76
EBIT
−359
−468
−241
−28
−86
Net financials
18
—
60
481
442
Profit before tax
11
13
51
736
84
Tax
−8
−11
−18
−163
−19
Net profit
3
2
33
573
65
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
15 256
14 183
14 182
14 395
14 705
Equity
12 896
12 898
10 931
11 504
11 570
Long-term debt
0
0
0
0
0
Short-term debt
947
395
2 632
2 600
2 814
Total debt
947
395
2 632
2 600
2 814
Financial ratios
5-year trend
EBITDA margin
-5.7%
This company
15.8%
Market median
136% below market
2021
2025
Equity ratio
78.7%
This company
38.2%
Market median
106% above market
2021
2025
Return on equity
0.6%
This company
18.4%
Market median
97% below market
2021
2025
Net profit margin
37.4%
This company
8.1%
Market median
362% above market
2021
2025
Asset turnover
0.01×
This company
1.12×
Market median
99% below market
2021
2025
Debt / equity
0.27×
This company
0.62×
Market median
56% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
View
PDF
More on Odeum Pharma AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
